Molecule Name |
DB09330
|
DrugBank Groups |
Approved
|
Cluster No |
1173
|
Smiles |
O=C(NC1(=C(N(CCN(C)C)C)C=C(OC)C(=C1)NC4(=NC(C=3(C2(=C(C=CC=C2)N(C=3)C)))=CC=N4)))C=C
|
Download |
mol2, pdbqt
|
TPSA |
87,55
|
Non-H Atoms |
37
|
Non-C/H Atoms |
9
|
Metal-Atoms |
0
|
Electronegative Atoms |
9
|
Stereo Centers |
0
|
Rotatable Bonds |
10
|
Rings Closures |
4
|
Small Rings |
4
|
Aromatic Rings |
4
|
Aromatic Atoms |
21
|
sp3-Atoms |
10
|
Symmetric atoms |
1
|
cLogS |
-4,455
|
MW |
499,617
|
cLogP |
3,4175
|
HBA |
9
|
HBD |
2
|
Ro5 violations |
0
|
Druglikeness |
-5,4185
|
DrugScore |
8,64895443967314E-02
|
Mutagenic |
high
|
Tumorigenic |
low
|
Reproductive Effective |
low
|
Irritant |
low
|
Blood-Brain Barrier |
BBB+
|
Human Intestinal Absorption |
HIA+
|
Caco-2 Permeability |
Caco2-
|
P-glycoprotein Substrate |
Substrate
|
P-glycoprotein Inhibitor |
Inhibitor
|
P-glycoprotein Inhibitor 2 |
Inhibitor
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Aqueous solubility |
-3,5494
|
Caco-2 Permeability 2 |
1,1232
|
Subcellular localization |
Mitochondria
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 2D6 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Substrate
|
CYP450 1A2 Inhibitor |
Inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 3A4 Inhibitor |
Inhibitor
|
CYP Inhibitory Promiscuity |
High CYP Inhibitory Promiscuity
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition 2 |
Inhibitor
|
AMES Toxicity |
Non AMES toxic
|
Carcinogens |
Non-carcinogens
|
Fish Toxicity |
High FHMT
|
Fish Toxicity (pLC50, mg/L) |
1,0211
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity (pIGC50, ug/L) |
0,5625
|
Honey Bee Toxicity |
Low HBT
|
Biodegradation |
Not ready biodegradable
|
Acute Oral Toxicity |
III
|
Rat Acute Toxicity (LD50, mol/kg) |
2,7363
|
Carcinogenicity (Three-class) |
Non-required
|